ERAS Earnings Date: Nov 11, 2026 (Estimated) — Erasca, Inc.
NASDAQ
Updated
When is ERAS's next earnings date?
Erasca, Inc. (ERAS) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.13.
How did ERAS do in its last earnings report?
In its most recent report on Aug 12, 2026, Erasca, Inc. posted EPS of -$0.14 versus the -$0.11 estimate, a miss of 25.7%. The stock's 1-day post-earnings move was -2.5%.
How much does ERAS stock move after earnings?
ERAS beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 2.9% (up or down) in the day after earnings.
About Erasca, Inc.
Erasca, Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on identifying, advancing, and commercializing therapeutic solutions for malignancies propelled by the RAS/MAPK pathway. The firm's pipeline features several key experimental drugs: ERAS-007, an orally administered ERK1/2 inhibitor designed to address non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor targeting patients with advanced or metastatic solid tumors. Additionally, Erasca is progressing ERAS-801, an EGFR inhibitor capable of penetrating the central nervous system, intended for recurrent glioblastoma multiforme. The company was founded in 2018 and maintains its headquarters in San Diego, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | -0.11 | -0.14 | -25.67% | — | ❌ Miss | -2.46% | -1.15% | -12.45% | |
| 2026-08-11 | Q2 2026 | -0.11 | -0.14 | -27.27% | $0 | ❌ Miss | +1.47% | -1.15% | -12.45% |
| 2026-05-11 | Q1 2026 | -0.22 | -0.60 | -172.73% | $0 | ❌ Miss | -0.57% | -1.63% | +28.07% |
| 2026-03-12 | Q4 2025 | -0.11 | -0.10 | +9.09% | $0 | ✅ Beat | -7.03% | +4.16% | +11.33% |
| 2025-11-12 | Q3 2025 | -0.11 | -0.11 | +0.00% | $0 | ➖ Inline | -4.15% | +4.15% | +35.85% |
| 2025-08-12 | Q2 2025 | -0.12 | -0.12 | +0.00% | $0 | ➖ Inline | +3.85% | -2.56% | +3.21% |
| 2025-03-20 | Q4 2024 | -0.13 | -0.11 | +15.38% | $0 | ✅ Beat | +3.38% | +4.73% | -16.22% |
| 2024-08-12 | Q2 2024 | -0.18 | -0.29 | -61.11% | $0 | ❌ Miss | +0.39% | +6.18% | +18.53% |
Showing last 8 quarters.